Acadia Pharmaceuticals | ACAD - Stock


Acadia Pharmaceuticals reported $34.67M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Acadia Pharmaceuticals USD 34.67M 5.57M Dec/2025
ALKERMES USD 196.62M 5.63M Dec/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
Biogen USD 2.17B 41.3M Dec/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Cara Therapeutics USD 900K 0 Mar/2025
Corcept Therapeutics USD 12.87M 519K Dec/2025
Cytokinetics USD 0 0 Dec/2023
Eisai JPY 236.46B 9.14B Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Incyte USD 101.06M 17.61M Dec/2025
J&J USD 14.58B 392M Mar/2026
Moderna USD 332M 92M Sep/2025
Neurocrine Biosciences USD 69M 300K Dec/2025
Pfizer USD 11.47B 201M Sep/2025
PTC Therapeutics USD 79.65M 26.96M Dec/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
Vanda Pharmaceuticals USD 1.85M 190K Dec/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025